Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.32 USD
-0.08 (-2.35%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $3.31 -0.01 (-0.30%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.74 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | 22.37% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.08 |
Next Year | -3.05 |
EPS (TTM) | -1.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 18.42M | 17.40M | 69.17M | 70.18M |
# of Estimates | 5 | 6 | 7 | 6 |
High Estimate | 28.63M | 33.63M | 100.97M | 100.32M |
Low Estimate | 3.10M | 3.10M | 45.00M | 30.54M |
Year ago Sales | 16.92M | 113.72M | 153.73M | 69.17M |
Year over Year Growth Est. | 8.89% | -84.70% | -55.01% | 1.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.74 | -0.75 | -3.08 | -3.05 |
# of Estimates | 9 | 7 | 8 | 8 |
Most Recent Consensus | -0.65 | -0.69 | -2.82 | -2.78 |
High Estimate | -0.54 | -0.50 | -2.82 | -1.96 |
Low Estimate | -0.89 | -0.92 | -3.26 | -3.84 |
Year ago EPS | -0.81 | 0.42 | -1.91 | -3.08 |
Year over Year Growth Est. | 8.64% | -278.57% | -61.26% | 0.85% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 5 | 6 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.74 | -0.75 | -3.08 | -3.05 |
7 Days Ago | -0.74 | -0.75 | -3.08 | -3.05 |
30 Days Ago | -0.74 | -0.75 | -3.08 | -3.05 |
60 Days Ago | -0.91 | -0.92 | -3.50 | -3.57 |
90 Days Ago | -0.91 | -0.92 | -3.50 | -3.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.74 | -0.75 | -3.08 | -3.05 |
Zacks Consensus Estimate | -0.74 | -0.75 | -3.08 | -3.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.95 | 0.42 | -0.81 | NA |
Estimate | -0.76 | -0.92 | -0.82 | -0.76 | NA |
Difference | 0.17 | -0.03 | 1.24 | -0.05 | 0.33 |
Surprise | 22.37% | -3.26% | 151.22% | -6.58% | 40.94% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more